1217 — China Innovation Investment Balance Sheet
0.000.00%
- HK$140.82m
- -HK$157.64m
- HK$20.26m
- 49
- 64
- 14
- 36
Annual balance sheet for China Innovation Investment, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 372 | 341 | 332 | 334 | 300 |
Net Total Receivables | 5.02 | 1.62 | 1.64 | 1.88 | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 378 | 344 | 335 | 337 | 335 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.23 | 1.34 | 0.831 | 2.56 | 1.59 |
Long Term Investments | |||||
Total Assets | 656 | 613 | 564 | 550 | 549 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.21 | 1.21 | 0.77 | 1.17 | 5.39 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 2.6 | 1.68 | 0.77 | 2.55 | 5.87 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 654 | 611 | 563 | 548 | 543 |
Total Liabilities & Shareholders' Equity | 656 | 613 | 564 | 550 | 549 |
Total Common Shares Outstanding |